Skip to content
  1. 2025
  2. 2023
  3. 2022
  4. 2021
  5. 2020
  6. 2019
  7. 2018

November 18, 2022

Neobiomics AB and ExCEEd Orphan s.r.o. announce an extended partnership for ProPrems® in Estonia, Latvia and Lithuania

Stockholm, Sweden, 17 Nov 2022 – Neobiomics AB and ExCEEd Orphan s.r.o. have …

November 1, 2022

ExCEEd Orphan announces new members of the team in several countries of the CEE region

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

August 1, 2022

Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases

Jerusalem, Israel and Prague, Czech Republic, August 1st, 2022. Rafa Laboratories LTD. (“Rafa”) …

July 15, 2022

ExCEEd Orphan announces new member of the EO Management team

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

July 13, 2022

ExCEEd Orphan announces partnership with Amryt to exclusively distribute Filsuvez® in Central and Eastern Europe (CEE)

Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to …

May 9, 2022

ExCEEd Orphan announces partnership with SERB to exclusively distribute Voraxaze® and DigiFab® in Central and Eastern Europe (CEE)

Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to …

May 4, 2022

ExCEEd Orphan announces opening of the third non-EU affiliate in Albania

The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions …

February 1, 2022

First sales of ProPrems in the CEE region

„ExCEEd Orphan and Neobiomics are happy to announce the first sales of ProPrems® …

February 1, 2022

ExCEEd Orphan announces new members of the team in Adriatic Region

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …